These veterans may be the future of cannabis-based pharmaceuticals
Blake speaks with Army veteran turned co-founder and CEO of RMR Laboratories, Mike Lui, about his over-the-counter cannabis pharmaceutica...
Our first product line targets chronic pain and sports injuries using CBD, which is non-psychoactive.
1 in 3 people in the United States suffer from chronic pain.
We decided to start with these applications because we saw an overwhelming need to develop a natural, effective alternative to pain killers with negative side effects, like opioids.
Here’s is a sample of what they’ve had to say:
The shortest duration of relief was 90 minutes. Some people had their pain go away completely after continued use. Every single trial user felt some type of pain relief.
The top layer of the skin, called the stratum corneum, is designed to protect the body by keeping harmful substances out.
The topicals designed by RMR Laboratories work by creating an intercellular pathway directly through the skin. The pharmaceutical technology has been shown to deliver active ingredients up to 25 millimeters below the skin in a non-toxic, non-traumatic way.
Our skin-penetrating technology provides a platform to quickly and efficiently address new health applications as well as build depth within current product lines.
We have only begun to scratch the surface on the therapeutic effects of different delivery systems and cannabis strains. In addition to topicals, we have future plans to expand into additional health and wellness product categories.
Our topicals address the source of the muscle or joint inflammation rather than try to mask the pain like existing pain relief creams do. NSAIDS can cause unwanted side effects like stomach irritation. Finally, unlike opioids, our pain relieving topicals have a localized effect, are not psychoactive (in the case of CBD), and are convenient to use because they do not impair motor function.
Our first three markets for product launch will be in Colorado, Oregon, and California. We are currently finalizing pre-orders from these three markets for $2.2M in revenue in the first half of 2018.
Our exclusive partnership with Advanced Nutrients for production and distribution expands our reach into every major market for medical and recreational cannabis, both in the US and internationally.
Our operating model allows us to scale quickly and efficiently. We centralize our research and production in California and ship the formula base without cannabis actives to each market where the end products are produced.
The proceeds from the campaign will be used on three priorities:
I believe in the power of high expectations on the performance of people and teams. I believe that everyone has a ceiling that they cannot see, but if they continue to strive and persevere, that high ceiling may come into view. That's why I believe in the power of the work we are doing at RMR Laboratories. If we can develop products to reduce people's pain in a meaningful way without paralyzing addictions or side effects, then we've given them a chance to set and strive for those high expectations.
Thank you for taking some time to learn about the work we are doing at RMR. I'm proud of the progress the team has made in such a short period of time. Our first flagship CBD formulation has garnered tremendous response from our trial participants and I can't wait to make it available to all those that experience chronic pain.
But we're just getting started, and I'm just as excited about the rest of our roadmap. We finally have the ability to use clinically valid transdermal technology to steer the healing properties of cannabis to where we need it. That to me is game-changing.
I hope you'll join us.
The smallest investment amount that RMR Laboratories is accepting.
$50,000 – $1,070,000
RMR Laboratories needs to raise
before the deadline. The maximum amount RMR Laboratories is willing
to raise is $1.07M.
RMR Laboratories needs to reach their minimum funding goal before the deadline.
If they don’t, all investments will be refunded.
The Crowd Safe is an agreement for future equity in the startup,
meaning that it can convert to equity in the future.
The Crowd Safe is an agreement for future equity in the startup, meaning that it can convert to equity in the future.
This is the most common question that we receive. The short answer is yes. If our topicals contain THC, you will receive a psychoactive effect from it and you will test positive on a drug test. For the first products we are launching in 2018 targeting chronic pain and sports injuries, the formulations contain only CBD, which is not psychoactive, and you will not get ‘high’.
Our roadmap for topicals is extensive and we have not even scratched the surface with regards to the health applications we can address. Having said that, we are also in the process of exploring other delivery systems and health and wellness categories, like nasal and sublingual sprays. One thing that we are not currently pursuing however is any edible or smoked products.
Chronic pain is officially defined as an unpleasant sense of discomfort that persists or progresses over a long period of time that is often resistant to medical treatments. On the other hand, acute pain suddenly arises in response to a specific injury, like a broken arm.
Our products contain active ingredients derived from cannabis and are subject to the regulations that cover those ingredients when it comes to interstate travel. We advise you consult with your local state and federal laws as appropriate.
Our products contain all natural ingredients that adhere to stringent quality standards. If you have any doubt, we advise you consult your medical professional prior to starting any new course of therapy.
No, our products are over-the-counter.
Chronic pain differs in severity and source. The short answer is to apply when you are feeling pain and proactively if you know what triggers your pain - for example, we have athletes apply to their knees prior to a run. You can reapply as needed.
Specific to transdermal delivery, it represents a true revolution. It's more efficient with active ingredients (you need less, which lowers product COGS), more consistent (because it takes a direct path), and creates more options for product development (because you remove a huge barrier to bodily absorption). Specific to other delivery methods - oral, needle - it's less traumatic, but also these other delivery methods serve other purposes.
RMR Laboratories successfully raised $784,479 from 952 investors on January 1, 2018
I invested in this because I realized what they are trying to accomplished and will be huge for the infrastructure as a wholeCosmas SmithInvested 7 months ago
I invested bc I truly believe the use of marijuana in a non-toxic way may be beneficial to improve body pain. RMR, I believe, has what it takes to achieve this goal and succeed in such innovative industry. Thank you for letting me be part of it.cornelia schepisInvested 9 months ago
I believe jn the future of this industry!Ajay WaghrayInvested 10 months ago
It might turn a big help to most people who has chronic pain.Romulo CabardoInvested 10 months ago
Wanted to be in on the ground floor of something I feel is going to grow.Rex CrewsInvested 11 months ago
I invested because I believe that this will be a great productMarc GordonInvested 11 months ago
Because believe that cannabinoids can be used for wellbeing of humans. investment $500.Winston VeerisInvested 11 months ago
I believe in the potential of the industry.Dianna ChenInvested 11 months ago
I see potential in this as I am someone who suffers from chronic pain. 100Terrence BillingsInvested 12 months ago
I believe in the medicine and feel that this company may have found a new method of delivering it to people in need across our hurting planet.Brady BriddleInvested 12 months ago
To help promote cannabis treatments and gain on investment.Harmesh VermaInvested 12 months ago
1. Fast growing market as a result of favorable regulatory environment. 2. Strong technology differentiates its product from competitors. 3. Implied forward revenue multiples are in line with those of comparable companies and transactions.Yating XiaInvested 12 months ago
Sounds like a good timely investment. I would invest more but you caught me on the tail end of several other larger investmentsDaniel RappaportInvested 12 months ago
I believe wholeheartedly in the benefits of cannabis! I also hope to make some money, although I can only invest $100.00.Krista RoseInvested 12 months ago
I have knee pain and believe in this product and the relief it can bring to those in pain.Melody DungeeInvested 12 months ago
I am retired from the pharmaceutical business and want to support this vision.Jeff JonesInvested 12 months ago
I believe in the product, glad to be a part of this.Jayse O'BrienInvested 12 months ago
I strongly agree that the demand will be there once product distribution begins.Joseph AmendolaInvested 12 months ago
I have wrist and elbow pain from my job and I believe this product will help relieve this painGREG TURKOInvested 12 months ago
i believe in this productMELISSA ROBINSONInvested 12 months ago
Investors should verify any issuer information they consider important before making an investment.
All securities-related activity is conducted by OpenDeal Portal LLC doing business as Republic, a funding portal which is registered with the US Securities and Exchange Commission (SEC) as a funding portal (Portal) and is a member of the Financial Industry Regulatory Authority (FINRA). Republic is owned by OpenDeal.
Investments in private companies are particularly risky and may result in total loss of invested capital. Past performance of a security or a company does not guarantee future results or returns. Only investors who understand the risks of early stage investment and who meet the Republic's investment criteria may invest.
Republic does not verify information provided by companies on this Portal and makes no assurance as to the completeness or accuracy of any such information. Additional information about companies fundraising on the Portal can be found by searching the EDGAR database.